Long-term brown coal mining contributes to risk element contents in soils surrounding coal basins. However, there is a lack of bioaccessibility characterization of the risk elements in the soils at the impacted locations for estimation of the potential health risk, in relation to the effects of soil particle size and element origin. In this study, soils from different geological areas (geogenic vs. anthropogenic) were sampled around the Most brown coal basin, Czech Republic. These soils were passed through sieves to obtain seven aggregate size fractions. For an estimation of the oral bioaccessibility of As and Pb in the size fractions, the physiologically based extraction test was applied, whereas the potential pulmonary bioaccessibility of the elements was estimated by using both Gamble's and Hatch's tests. The results showed that the geochemical pattern of the investigated elements clearly separates the soil samples collected from the mountain region (mineralization from geogenic processes) from those of the basin region (extensive coal mining). For As, the results indicated that it poses higher risks in the anthropogenically affected basin region due to its higher gastro-intestinal and pulmonary bioaccessibility in soil samples in this area. A higher bioaccessibility of As in the soils was recorded in the finer grain size fractions, which are usually air-borne and can be easily ingested and/or inhaled, leading to potential health risks to humans and livestock. The opposite pattern, with a higher content on coarse particles, was recorded for Pb, indicating a potential risk of livestock in the non-forest mountainous areas.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10653-021-01008-8 | DOI Listing |
AAPS J
January 2025
Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, 4000, Liège, Belgium.
In addition to the known therapeutic indications for cannabidiol, its administration by inhalation appears to be of great interest. Indeed, there is evidence of cannabidiol's efficacy in several physiological pathways, suggesting its potential for a wide range of applications for both local and systemic pulmonary administration like cancers. Significant advances in pulmonary drug delivery have led to innovative strategies to address the challenges of increasing the respirable fraction of drugs and standardizing inhalable products.
View Article and Find Full Text PDFJ Appl Clin Med Phys
January 2025
Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, Illinois, USA.
Background: Various methods exist to correct for intrafraction motion (IFM) of the prostate during radiotherapy. We sought to characterize setup corrections in our practice informed by the TrueBeam Advanced imaging package, and analyze factors associated with IFM.
Methods: 132 men received radiation therapy for prostate cancer with a volumetric modulated arc therapy technique.
Front Cardiovasc Med
January 2025
Department of Cardiovascular Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Background: Atrial fibrillation (AF) is a prevalent cardiac arrhythmia, with ventricular rate control being a critical therapeutic target. However, the optimal range for ventricular rate control remains unclear. Additionally, the relationship between different levels of ventricular rate control and cardiac remodeling in patients with atrial fibrillation remains unclear.
View Article and Find Full Text PDFEndocr Oncol
January 2024
Department of Oncology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden.
Summary: Craniopharyngiomas (CPs) are rare brain epithelial tumours arising in the suprasellar region, infiltrating adjacent areas causing visual loss, panhypopituitarism, cognitive deficits and morbid obesity. Papillary CPs (PCPs) harbour in 94% BRAF mutation cases. Two patients with PCP and BRAF V600E mutations but with different tumour status were treated with BRAF and MEK inhibitors.
View Article and Find Full Text PDFESC Heart Fail
January 2025
School of Clinical Medicine, Fujian Medical University, Department of Cardiology, Affiliated Hospital of Putian University, Putian, China.
Purpose: Vericiguat, a soluble guanylate cyclase (sGC) stimulator, has been demonstrated effective in improving prognosis of patients with heart failure with reduced ejection fraction. However, there are limited data concerning the effect of vericiguat in patients with doxorubicin (DOX)-induced cardiomyopathy (DIC). In this study, we investigated the effects of vericiguat on cardiac structure and function in rats with DIC as well as their potential mechanisms of action.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!